Does a Spate of Manager Departures at T. Rowe Price Signal Trouble?
Three key stock fund managers have left or are leaving soon. If you invest in Price funds, here’s what to do now.

Corporate culture is, in my view, a key determinant of a fund company's success. This is just common sense. When people hate to come to work every morning, they don't usually do their best work. When they work together and share ideas, they tend to succeed more often than they fail.
I mention this because I was shocked to hear of the recent departures of three key U.S. stock fund managers, along with a couple of top analysts, from T. Rowe Price. I've always considered Baltimore-based T. Rowe one of the nation's best-run fund outfits. One manifestation of that is the company's low manager turnover — three managers typically leave about every five years, not in a few months. Many managers spend their entire careers at Price. So I can't help but worry whether the spate of departures signals a fundamental change at the company.
Take a look at the damage. Kris Jenner, manager of top-performing T. Rowe Price Health Sciences (symbol PRHSX), along with two health analysts, left to start a hedge fund. Under Jenner, who had run the fund since 2000, it returned an annualized 11.0% until his February 14 departure. That compares with an annualized 2.2%% over the same period for Standard & Poor's 500-stock index. Health Sciences' new manager is Taymour Tamaddon, previously an analyst at the fund.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.

Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
An equally big blow was the departure on May 10 of Joseph Milano, who had managed T. Rowe Price New America Growth (PRWAX) superbly since 2002. Under his stewardship, the fund returned an annualized 10.2% — an average of 1.5 percentage points per year better than the S&P 500. Milano may start a hedge fund, too.
Daniel Martino has taken over from Milano. Martino put up good numbers in 3½ years managing T. Rowe Price Media and Telecommunications Fund (PRMTX). But he lacks experience running a diversified fund or a fund as large as New America Growth, which contains $4 billion in assets.
Meanwhile, Tim Parker has announced his resignation as manager of T. Rowe Price New Era (PRNEX), a natural resources fund, after less than three years on the job. That's perplexing because Parker has worked at T. Rowe since 2001 and was groomed for years to take over New Era. Returns were mediocre under his leadership, however. Parker will leave by September 30 and be replaced by Shawn Driscoll, who has been a natural resources analyst at Price for the past seven years.
John Linehan, head of U.S. stock funds at Price, is unhappy about the cluster of resignations. But, he says, "we've seen this play before." In 2001 and 2002, four T. Rowe managers left in a short period. "Obviously, the recent turnover has been disappointing," Linehan says. "It's never any fun to go through. But it emphasizes the importance of having a deep bench. Which is why we go out and hire the best people we can find and then work hard to develop their talents so that they can be ready to take over a fund."
The company's culture hasn't changed at all, Linehan says: "Collegiality and collaboration are crucial to us. We reward people who work well with each other, trading insights and expanding on one another's investment ideas."
The manager is, of course, the most important person at any fund. Anytime a manager leaves, you need to take careful notice. At the same time, manager losses at big fund shops such as Price historically haven't been as devastating as manager departures from small firms, where the manager is pretty much synonymous with the fund.
The bottom line: I'm willing to give Linehan and T. Rowe the benefit of the doubt. But I see no reason to commit new money to any of the three affected funds. If you own them, you have a tough choice. It's hard to find a good health-sector fund as broad as T. Rowe's, which holds a healthy dose of biotech stocks as well as drug and health insurance companies. I'd probably give the new manager a year to prove himself. But I'd probably sell New America Growth — there are plenty of good growth funds. And I'd sell New Era — the natural resources sector doesn't appeal to me, anyway.
My favorite Price funds include Capital Appreciation (PRWCX), Mid-Cap Growth (RPMGX) and all of the firm's retirement funds. The retirement funds hold other Price funds, with their division between stock and bond funds becoming increasingly conservative as shareholders approach retirement. With the departures of Jenner and Milano, T. Rowe boasts fewer exceptional funds, but most are still pretty good.
Steven T. Goldberg is an investment adviser in the Washington, D.C. area.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

-
Market Fees Could Be Costing You — Here’s How to Avoid Them
Some money market accounts charge more than they earn. Here's how to spot costly fees and choose smarter savings options.
-
The Role of a Mortgage Underwriter in Buying a Home
From fast-track approvals to manual reviews, here’s what to expect (and how to avoid delays) in the underwriting process.
-
Stocks Slide to Start September: Stock Market Today
Seasonal trends suggest tough times for the stock market as we round into the end of the third quarter.
-
Stocks End Strong Month on a Down Note: Stock Market Today
There was likely a bit of profit-taking ahead of a historically weak September.
-
S&P 500 Tops 6,500 Even as Nvidia Slips: Stock Market Today
The world's most valuable company closed lower after earnings, but the S&P 500 managed to notch a new record high.
-
Stocks Edge Higher With Nvidia, Fed in Focus: Stock Market Today
The AI bellwether reports earnings after today's close, while Wall Street is keeping a cautious eye on President Trump's attacks against the Fed.
-
President Trump Makes Markets Move Again: Stock Market Today
The White House is moving ahead with plans to reshape the Federal Reserve and to buy shares in more sectors and stocks.
-
Stocks Struggle to Start Nvidia Week: Stock Market Today
Another important week for the stock market starts on a risk-off note.
-
Dow Rips 846 Points to New All-Time High: Stock Market Today
Fed Chair Jerome Powell seems ready to cut interest rates in the fall but will still rely on incoming economic data about inflation and employment.
-
S&P 500 Extends Losing Streak Ahead of Powell Speech: Stock Market Today
Stocks continued to struggle ahead of Fed Chair Powell's Friday morning speech at Jackson Hole.